French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10CS): Predictive Factors of Poor Compliance (FACE)

Study Overview
=================
Brief Summary
-----------------
The purpose of this study is to determine the predictive factors of poor compliance to sleep disordered breathing therapy in chronic heart failure patients treated for central sleep apnea. To characterize nocturia pathophysiology associated with SDB in this population. To use telemonitoring data to define predictive factors of poor compliance.

Official Title
-----------------
French Cohort Study of Chronic Heart Failure Patients With Central Sleep Apnoea Eligible for Adaptive Servo-Ventilation (PaceWave, AutoSet CS, AirCurve 10 CS): Predictive Factors of Poor Compliance

Conditions
-----------------
Central Sleep Apnea, Heart Failure

Intervention / Treatment
-----------------
* Other: telemonitoring


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: Adult Patient with Chronic Heart Failure Central Sleep Apnea requiring Adaptative Servo-Ventilation therapy Patient is able to fully understand study information and signed informed consent Exclusion Criteria: Contra-indications to Adaptative Servo-Ventilation therapy Respiratory Failure or Hypercapnia inconsistent with Adaptative Servo-Ventilation therapy

Ages Eligible for Study
-----------------
Minimum Age: 18 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: telemonitoring|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| to define the phenotype of compliant or not compliant patients to sleep disordered breathing therapy using microneurography | Autonomic nervous system balance measure by microneurography | 12 months | 

Secondary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| anxiety and nervous depression | using Spielberger questionnaire and Beck's Depression Inventory | 12 months | 
| sleep disordered breathing symptomatology | using Epworth sleepiness scale and Oxford Sleep Resistance Test | 12 months | 
| Nocturia | evaluated by number of urination per night, diuresis, plasmatic dosage of Atrial Natriuretic peptide, Brain natriuretic peptide, Antidiuretic hormone | 24 months | 
| sleep quality | evaluated by Pittsburgh Sleep Quality Index; minnesota living with heart failure questionnaire; actimetry; home polysomnography | 24 months | 
| Heart Failure status | evaluated by echocardiography, New York Heart Association functional classification; Electrocardiography | 24 months | 
| therapy compliance | evaluated by Morisky Medication Adherence Scale and with telemonitoring data | 24 months | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
Adaptive servo-ventilation, telemonitoring